Generic name: FlunisolideBrand names: Nasalide, AeroBid-M, AeroBid
AeroBid is prescribed for people who need long-term treatment to control and prevent the symptoms of asthma. It contains an anti-inflammatory steroid type of medication and may reduce or eliminate your need for other corticosteroids. A nasal-spray form of the drug (Nasalide) is available for relief of hay fever.
AeroBid helps to reduce the likelihood of an asthma attack, but will not relieve one that has already started. To be effective as a preventive measure, it must be taken every day at regularly spaced intervals. It may be several weeks before you receive its full benefit.
Take AeroBid at regular intervals, exactly as prescribed by your doctor.
To help reduce hoarseness, throat irritation, and mouth infection, rinse out with water after each use. If your mouth is sore or has a rash, tell your doctor.
Illustrated instructions for use are available with the product.
Side effects cannot be anticipated. If any develop or change in intensity, inform your doctor as soon as possible. Only your doctor can determine if it is safe for you to continue taking AeroBid.
This medication is not for treatment of prolonged, severe asthma attacks where more intensive measures are required.
If you are allergic or sensitive to AeroBid or other steroid drugs, advise your doctor. This medication may not be right for you.
Your asthma should be reasonably stable before treatment with AeroBid Inhaler is started. AeroBid should be started in combination with your usual dose of an oral steroid medication. After approximately 1 week, your doctor will start to withdraw gradually the oral steroid by reducing the daily or alternate daily dose. A slow rate of reduction is very important, as some people have experienced withdrawal symptoms such as joint and/or muscular pain, fatigue, and depression. Tell your doctor if you lose weight or feel light-headed. You may need to take more oral corticosteroid temporarily.
This medication is not useful when you need rapid relief of asthma symptoms.
Transferring from steroid tablet therapy to AeroBid Inhaler may produce allergic conditions that were previously controlled by the steroid tablet therapy. These include rhinitis (inflammation of the mucous membrane of the nose), conjunctivitis (pinkeye), and eczema.
Contact your doctor immediately if you have an asthma attack that isn't controlled by a bronchodilator while you are being treated with AeroBid. You may need an oral steroid drug.
While you are being treated with AeroBid, particularly at higher doses, your doctor will carefully observe you for any evidence of side effects such as the suppression of glandular function and diminished bone growth in children. If you have just had surgery or are under extreme stress, your doctor will also closely monitor you.
The use of AeroBid may cause a yeastlike fungal infection of the mouth, pharynx (throat), or larynx (voice box). If you suspect a fungal infection, notify your doctor. Treatment with antifungal medication may be necessary.
Since the contents of this inhalant are under pressure, do not puncture the container and do not use or store the medication near heat or an open flame. Exposure to temperatures above 120 degrees may cause the container to explode.
People taking drugs such as AeroBid that suppress the immune system are more open to infection. Take extra care to avoid exposure to measles and chickenpox if you've never had them or never had shots. Such diseases can be serious or even fatal when your immune system is below par. If you are exposed, tell your doctor immediately.
Also, if you have tuberculosis, a herpes infection of the eye, or any other kind of infection, make sure the doctor knows about it. You probably should not use AeroBid.
No interactions have been reported.
The effects of AeroBid during pregnancy have not been adequately studied. If you are pregnant or plan to become pregnant, inform your doctor immediately. It is not known whether AeroBid appears in breast milk. If AeroBid is essential to your health, your doctor may advise you to discontinue breastfeeding your baby until your treatment with AeroBid is finished.
The AeroBid Inhaler system is for oral inhalation only.
The recommended starting dose is 2 inhalations twice daily, in the morning and evening, for a total daily dose of 1 milligram. The daily dose should not exceed 4 inhalations twice a day, for a total daily dose of 2 milligrams.
For children 6 to 15 years of age, 2 inhalations may be used twice daily, for a total daily dose of 1 milligram.
The safety and effectiveness of AeroBid have not been established in children under 6 years of age.
Any medication taken in excess can have serious consequences. If you suspect an overdose, seek emergency medical treatment immediately.